Abstract:Dear Editor, In a recent paper in Diseases of the Esophagus, Zhang and colleagues conclude that “The number of lymph node metastases influences survival and International Union Against Cancer tumor-nodemetastasis classification for esophageal squamous cell carcinoma.” However, in their subgroup of patients, the average lymph node yield (LNY) is less than 4 (1146 patients with 4270 LNs harvested), and the number is too low to appropriately evaluate the International Union Against Cancer (UICC) tumor– node–metastasis classification for esophageal cancer. The current UICC classification demands for six LNs for pathologic lymph node (pN) staging. It is considered that the minimal regional LNY of six LNs as recommended by the UICC for esophageal carcinoma is far too low to appropriately stage the disease. Based on an international study including 3651 patients, Peyre et al. concluded that the number of LNs removed is an independent predictor of survival after esophagectomy for cancer, and to maximize this survival benefit, a minimum of 23 regional LNs must be removed. In Dr Rizk’s analysis, a total of 4627 patients who had esophagectomy alone for esophageal cancer were identified from the Worldwide Esophageal Cancer Collaboration database. Optimum number of nodes that should be resected to maximize 5-year survival was determined by random forest multivariable regression. Rice et al. concluded that greater extent of lymphadenectomy was associated with increased survival for all patients with esophageal cancer except at extremes (TisN0M0 and 7 regional LNs positive for cancer) and welldifferentiated pN0M0 cancer; they also considered that maximum 5-year survival was modulated by T classification: Resecting 10 nodes for pT1, 20 for pT2, and 30 for pT3/T4 was recommended. Surveillance, Epidemiology and End Results data suggest that patients undergoing surgical resection for esophageal cancer should have at least 18 LNs removed. Recently, Jamieson et al. reviewed the role of lymphadenectomy in esophageal cancer, and it is considered that from a staging and theoretical oncologic point of view, extended lymphadenectomy is preferred. From the perspective of Dr Jamieson, the role of LNY was also highlighted. Although the effect of the number of positive LNs was analyzed, the LNY is not enough to reflect the LN status of the patients in the paper by Zhang and colleagues, and the authors did not discuss the effect of LNY on the staging of esophageal cancer, so we have outlined the issue here.

Spirited discussion: lymph node count versus nodal station count

Distribution and prognosis of mediastinal lymph node metastases of nonsmall cell lung cancer.

Role of Number of Sentinel Nodes in Predicting Non-Sentinel Node Metastasis in Breast Cancer

Lymphadenectomy for clinical early-stage non-small-cell lung cancer: a systematic review and meta-analysis.

Proposal Of The Optimal Numbers Of Examined And Positive Lymph Nodes To The 8th Edition Of American Joint Committee On Cancer (Ajcc) Staging For 758 Patients With Distal Cholangiocarcinoma

The Extent of Mediastinal Lymph Node Dissection Correlates with Survival of Small Cell Lung Cancer Patients after Resection: a Propensity Score-Matched Cohort Study Analysis.

Lymph Node Counts and Ratio in Axillary Dissections Following Neoadjuvant Chemotherapy for Breast Cancer: A Better Alternative to Traditional Pn Staging

Effect of Lymph Node Assessment on Outcomes in Surgery for Limited Stage Small Cell Lung Cancer

Mediastinal lymphadenectomy fulfilling NCCN criteria may improve the outcome of clinical N0-1 and pathological N2 non-small cell lung cancer.

Minimizing residual occult nodal metastasis in NSCLC: recent advances, current status and controversies

The Number of Lymph Node Metastases Influences Survival and International Union Against Cancer Tumor-Node-metastasis Classification for Esophageal Squamous Cell Carcinoma: Does Lymph Node Yield Matter?

The Least Nodal Disease Burden Defines the Minimum Number of Nodes Retrieved for Esophageal Squamous Cell Carcinoma

A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database

Commission on Cancer Standards for Lymph Node Sampling and Oncologic Outcomes After Lung Resection

Assessing the Adequacy of Lymph Node Yield for Different Tumor Stages of Colon Cancer by Nodal Staging Scores.

Pathologically Examining a Minimum of Three Lymph Nodes Could Better Determine Node Negativity in Patients with Non-Metastatic Chromophobe Renal Cell Carcinoma

Association Between Lymph Node Examination and Nodal Staging for Pancreatic Adenocarcinoma: A Population-Based Analysis.

Lymph node dissection in lung cancer surgery

Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the Us Seer Database and A Chinese Multi-Institutional Registry

A Large Real-World Cohort Study of Examined Lymph Node Standards for Adequate Nodal Staging in Early Non-Small Cell Lung Cancer.

Impact of examined lymph node count on survival outcomes in patients with stage T1-2N0M0 small cell lung cancer undergoing surgery: A retrospective cohort study